Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC

Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC

IntroductionTumor acidity is emerging as a hallmark of cancer and carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) expression is frequently increased in acidic tumors. L-DOS47, a novel antibody-drug conjugate (ADC), consists of jack bean urease cross-linked to anti-CEACAM6 nanobod...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodryg Ramlau, Dariusz M. Kowalski, Aleksandra Szczęsna, Cezary Szczylik, Young Ou, Martin Köbel, Gabrielle M. Siegers, Kim J. Gaspar, Brenda Lee, Kazimierz Roszkowski-Sliz
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
tumor microenvironment
ADC
nanobody-drug conjugate
CEACAM6
CEACAM-6
acidosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1544967/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1544967/full

Similar Items